Skip to main content
PLOS One logoLink to PLOS One
. 2025 Apr 24;20(4):e0321178. doi: 10.1371/journal.pone.0321178

Allostatic load and its determinants in a German sample—Results from the Carla cohort

Eric Priedemann 1,*, Alexander Kluttig 1, Frank Bernhard Kraus 2, Daniel Sedding 3, Rafael Mikolajczyk 1, Amand Führer 1
Editor: Andrey I Egorov4
PMCID: PMC12021213  PMID: 40273157

Abstract

Background

Allostatic load (AL) is a surrogate of the physiological response to stress and reflects the ‘wear and tear’ on the body. Previous studies indicated that socioeconomic and behavioral determinants influence AL, which in turn is associated with health outcomes. Therefore, AL is increasingly used to operationalize the relationship between social inequality, stress, and health outcomes. This study aimed to investigate associated factors and patterns of AL in the population over a 20-year period using data from the CARLA cohort.

Methods

The analysis included 473 participants from the CARLA study (Cardiovascular Disease, Living and Ageing in Halle), aged 45–80 years at baseline. From recruitment in 2002 in Halle (Saale), three follow-up examinations took place until 2022. We calculated AL scores as the sum of standardized z-scores for metabolic, immune, cardiovascular, and anthropometric components. Descriptive statistics of AL scores were stratified by sex and age categories. Multiple regression analyses were conducted for the first and third follow-up to assess if there were changes in associations between sociodemographic factors and AL.

Results

Average AL scores of men decreased, while women’s AL scores returned to baseline levels after an initial decrease observed at the first follow−up. Stratified analyses of AL scores revealed that women in the younger age cohorts had lower mean AL scores at baseline than men (women: −3.47, 95% CI [−4.24; −2.71] vs. men: −1.13, 95% CI [−1.84; −0.42] at age <55). At the same time, women showed higher mean AL scores than men in older age cohorts (women: −0.32, 95% CI [−1.58; 0.95] vs. men: −0.93, 95% CI [−1.99; 0.14] at age 65−<70).

Results of multiple regression models indicated lower AL scores for women (β: −1.21, 95% CI [−1.93, −0.49]). Professional status was associated with lower AL scores for men but not for women (β: −1.06, 95% CI [−2.02, −0.11] for men). Further, physical activity was negatively associated with AL scores for the total study sample and for women (β: −0.54, 95% CI [−0.82, −0.26]) for total sample and β: −0.74, 95% CI [−1.17, −0.32] for women).

Conclusion

Our results highlight the importance of health awareness and physical activity for overall health, assessed by AL. Distinct AL score changes and sex-specific socioeconomic influences offer insights into sex-related patterns of aging. Further research is needed to understand the underlying mechanisms of socioeconomic influences on stress-related aging processes between sexes.

Introduction

Allostatic load as embodiment of stress

Stress is a psychophysiological response of the body to achieve adaption to challenging stressors [1,2]. In this regard, acute stress leads to a physiological adaption to maintain homeostasis if short-term stressors occur. Chronic stress must be distinguished from this physiological response because of the long-lasting character of chronic stressors, which ultimately lead to maladaptive responses of the body [1,3]. This results in the secretion of hormones that affect various organs including the heart, liver, kidney and brain. Several studies have focused on the measurement of chronic stress and investigated multiple biomarkers as a surrogate of chronic stress [3]. One of the most common methods to quantify the physiological response to stressors is Allostatic Load (AL) [4,5]. The concept of AL is based on the concept of allostasis, the organism’s attempt to adapt to external influences through a reaction of different organ systems to preserve physiological stability [6]. As such, AL describes the physiological cost of chronic exposure to stress and shows the cumulative “wear and tear” on the body as a result of the constant release of stress hormones [6]. The underlying mechanism consists of the activation of the physiological stress system that initiates the release of measurable mediators. These mediators are used to operationalize AL and can be quantified as an allostatic load score [7,8]. Primary mediators, as part of the first systems to be activated through stress include the neuroendocrine and the immune system [4,5,9].

The main pillars of the neuroendocrine system are the hypothalamic–pituitary–adrenal axis and the sympathetic–adrenal–medullary system, which can be quantified through their metabolites such as cortisol, epinephrine, norepinephrine, dopamine, aldosterone or dehydroepiandrosterone.

Increased primary mediators lead to secondary systemic dysregulation that reflect the cumulative effects in specific tissues or organs [10]. Secondary systemic dysregulation in the metabolic, inflammatory and cardiovascular system are measured by biomarkers for each system [11]. Hence, frequently used biomarkers from the secondary systems such as systolic blood pressure, diastolic blood pressure, waist–hip ratio, high-density lipoprotein cholesterol, total cholesterol, and glycated hemoglobin [8,10] can be considered as the result of compensation for dysregulated stress hormones [4].

Over time, the sustained secretion of stress hormones and subsequent dysregulation in different organ systems can lead to various negative health outcomes, including cardiovascular disease, diabetes, and depression [11]. Thus, AL has been established as a better predictor for mortality [12–15], diabetes mellitus, cardiovascular and other chronic diseases than any single parameter included in the AL score alone [11,13,16].

Influencing factors of AL

Various determinants of AL have been identified in the literature [17]. In addition to psychosocial [18] and individual behavioral factors [19], studies have shown that socioeconomic factors [20] are associated with AL. In this regard low individual socioeconomic status (SES), defined by low household income [21] and low education [22,23] was associated with high values of AL in previous studies. Other investigations found high socioeconomic position to be related to low AL, which seems to confirm this correlation [24–29].

Further, adverse working conditions and job insecurities seem to have a negative impact on AL [11]. Increased job demands without social support or decision latitude, were associated with higher allostatic load levels in men older than 45 years after controlling for smoking status and age [30]. It has also been shown that vital exhaustion, an effort–reward imbalance and burnout symptoms were associated with higher allostatic levels in female school teachers [31].

In addition, there is considerable amount of evidence on lifestyle habits being associated with AL, such as physical activity [17,32,33], sleep quality [34,35], diet and weight [36–40], alcohol consumption [17,33,41] and smoking habits [42].

In this context, AL has evolved to operationalize the relationship between social inequality, stress and health outcome, and allows to study the relations of social stressors on individuals’ health [10,11,20].

Sex-specific differences in AL

Some studies suggest that women have or develop higher levels of AL than men, particularly in response to certain stressors such as caregiving [43,44].

Overall, the results with regard to sex-specific changes in AL over the life-course are inconsistent [43,45,46]: A cross-sectional study within the US population showed higher AL scores for women than for men and increased differences between sexes at ages over 60 years [43], while a longitudinal cohort study from England found higher AL scores for men and similar changes of AL over time for both sexes [45]. Besides that, the selection of biomarkers for the calculation of AL scores may impact AL score differences between the sexes [43,47]. Previous research also found sex-specific associations between socioeconomic status and AL scores [48]. Since socioeconomic status and other determinants may play a role in an individual’s AL, more research is needed to understand the potential sex differences in AL and their change over time [11].

Age and allostatic load

An increase in AL with age has been shown. This is, among other things, based on the accumulation of stressors over time and can also be explained by an increased dysregulation in organ systems with age [14,45,49]. Beyond that, multiple studies have found an association of AL with frailty [16,50–52] as well as with decline in cognitive and physical functioning [14,15,52–54].

Measurement of AL

Commonly a combination of multiple physiological markers is used to create an overall AL score [8]. Since there are plenty of studies measuring AL, there is tremendous variation concerning the measurement of AL [8,10]. The most frequent way to calculate AL scores, is to convert each biomarker into a dichotomous variable, attributing one point to the biomarker if it falls in its high-risk range and 0 points if does not. Hereby, high risk is most commonly determined by the highest or (respectively lowest) quartile measured for each biomarker [10,55]. Still, there is a broad agreement that biomarkers from at least three organ systems (cardiovascular, metabolic and immune) should be used to measure AL, and the score should contain biomarkers of both primary and secondary mediators [8]. Further, most authors agree that the use of medication that affect the included organ systems (i.e., anti-hypertensive, lipid-lowering or antidiabetic medication) should be accounted for by various methodic approaches [8].

Research gap and aim of the study

Despite the existence of longitudinal data on determinants of AL, there is still a limited availability of data that includes multiple measurements of AL throughout an individual’s life span [45,46,56]. Only few studies investigated the longitudinal pattern of AL based on repeated measurements in community-based cohorts including over a long period [13]. Moreover, previous research on the relationship between determinants and AL has primarily concentrated on AL as the outcome measured at a single point in time. This approach overlooks associations that may exist for specific durations or exhibit cumulative effects.

This highlights substantial research gaps that can be explored through a longitudinal study of AL over nearly two decades within a cohort study. While cross-sectional studies have reported higher AL scores at older ages, longitudinal investigations of this association within a consistent cohort over extended time periods are lacking [13].

Furthermore, the question arises of how AL changes in different subpopulations within a cohort and whether differences can be identified for these subpopulations. Findings on sex-specific differences in AL have been described but also reveal similar methodological limitations. Studies investigating the longitudinal pattern of AL by sex show inconsistent results and often focus on shorter observation periods [45,46]. Further, associations between age and AL within a cross-sectional framework do not provide insights into generation- or age-cohort-specific relationships.

Within the scope of a longitudinal investigation of AL, we can explore potential changes of AL over time across sex and various age cohorts, thereby advancing the current state of research.

To investigate longitudinal patterns of AL, we focused especially on sex- and age-specific relationships of socioeconomic and individual behavioral factors with AL in the CARLA-cohort over a period of almost 20 years. Due to the comprehensive examinations at multiple points in time and the large number of parameters, data of the CARLA study provides the chance to investigate longitudinal changes of AL levels. Hereby, this work pursues the following questions:

  1. Do mean AL scores change in the CARLA-cohort over the study period for CARLA?

  2. Do mean AL scores change differently for men and women and within age-groups?

  3. Do the associations between socioeconomic and behavioral factors with AL scores change over time?

Methods

The study population and data source

This article is based on an analysis of data from the CARLA study, a prospective cohort study that investigates risk factors for cardiovascular diseases and determinants of successful ageing. Detailed description of the CARLA study was published elsewhere [57–59]. The CARLA study has been approved by the responsible ethics committee (registration number: 164/12.10.05/1). For this analysis, no additional ethics clearance was required. In brief, the cohort was recruited using the population registry of the city of Halle. The baseline examination took place July 2002 through January 2005, followed by the first follow-up examination between March 2007 and March 2010. The second follow-up took place between January and October 2013, and the third between October 2020 and March 2022 [59]. The data was accessed for this research in November 2022.

The participation proportion was 64.1% (68.6% for men and 59.5% for women) and the retention proportions were 81%, 77%, and 27% of the original cohort through follow-up examinations 1–3, respectively (Fig 1). The study population showed a high prevalence of hypertension (74%), type 2 diabetes (15%) and a high average Body Mass Index (BMI) (28 kg/m2) at baseline [58]. As the second follow-up does not contain laboratory parameters that are needed to calculate AL, we decided to utilize data of the baseline (CARLA-0), first (CARLA-1) and third follow-up (CARLA-3) examinations for this analysis. Given the loss of participants over time, we included only those who participated in each follow-up. Since this approach can potentially lead to selection bias, we conducted a descriptive and analytical sensitivity analysis. We present descriptive summaries of the entire study sample (n = 1779) compared to the subsample (n = 473) in the supplement (S1 Table). Further, we tested differences between these samples using t−test (continuous variables) or χ2 test (categorical variables). We report the mean difference and 95% confidence intervals: Participants who attended at all examinations were found to be younger at baseline (−6.6 years, 95% CI: [−7.4; −5.8]), had higher income, educational level and professional status, reported fewer pack−years of tobacco use (7.5 versus 10.4; 95% CI: [−4.19; −1.69]), engaged in more hours of physical activity per week (0.95 versus 0.75, 95% CI: [0.05; 0.35]), and had a lower proportion of medication use (e.g., antihypertensive medication, 0.38 versus 0.55, χ2= 77.201, p−value: <2.2e−16). Solely, consumption of alcohol (g per day, 12.0 versus 11.4, 95% CI: [−0.89; 2.19]) was not found to be different between the subgroup and the whole sample. To assess the impact of missing at random on our results, we conducted the linear regression models for the entire population of CARLA−0 (n = 1779) and CARLA−1 (n = 1436) and compared these with the results of the regression models for the subpopulation of CARLA−0 (n = 473) and CARLA−1 (n = 473). Since the effect estimates differed only nominally, but not in their direction and significance, we decided to proceed with the analysis of the subpopulation to ensure data comparability of the study population over time without distorting the estimated effects.

Fig 1. Flow chart: Retention proportion and subsample of the CARLA cohort.

Fig 1

Allostatic load measurements and allostatic load score

We calculated an AL score to measure biological dysregulation at baseline and follow-up examinations 1 and 3 by gathering data on metabolic, immune, cardiovascular and anthropometric measures. Anthropometric indicators included waist circumference and body-mass index (BMI). As metabolic measurements, we used triglycerides (TG), low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL), and glycated hemoglobin (HbA1c). Cardiovascular measures included systolic and diastolic blood pressure, while c-reactive protein (CRP) was used for immune measurement. As non-fasting venous blood samples were used at each examination time point (59), we highlight the intraindividual measurement variability of the metabolic biomarkers. While HDL and LDL exhibit intraindividual variability of 4–8% (for HDL) and 5–10% (for LDL), respectively, triglycerides may show higher variability of 20–30%, depending on factors such as the time of measurement and diet [60–63]. Due to the availability of single measurements at each follow-up, a methodological consideration of these intraindividual variabilities is not possible. Blood pressure was measured three times following an initial 5-minute rest period, with a 3-minute break between each measurement. The final blood pressure values are the average of the last two readings [59].

Due to missing biomarker data for a few participants, resulting in missing AL scores, we imputed the absent biomarkers using the mice-function in R studio [64]. Since nine biomarkers were measured at baseline and two follow-ups, there are 27 measurements. Of these 27 variables, eight variables were complete for all study participants. For 13 of the variables, there were a maximum of five missing data points. For another six variables, there were up to 33 missing data points. A detailed breakdown of the missing data points can be found in the supplement (S2 Table).

In order to summarize these measurements, we first calculated standardized z-scores for each of the nine indicators. We then summed standardized z-scores of all parameters for each individual to create an AL score at baseline and follow-up examinations 1 and 3. The approach of using z-scores to calculate AL scores has become established through its utilization in numerous studies [4,23,65,66] and provides the opportunity to account for the continuity of the measured variables [65]. To enable a comparison of AL over time, we calculated standardized z-scores using cut points for higher risk derived from clinical guidelines. We set these clinical cut points as zero to indicate where each individual’s value placed them (in SD units) relative to these cut points. The clinically established cut points used in our analysis are shown in Table 1. A high standardized score implies a higher risk except for high-density lipoprotein. To reflect lower values of high-density lipoprotein corresponding to higher biological risk and to create a concurring score, we multiplied the standardized score of high-density lipoprotein by –1 before calculating the AL score. We decided to calculate the AL score by adding up z-scores of each parameter as it allows the weight of each biomarker to be equal depending on its deviation from the cut-point’s mean. Despite our reasoned decision to use z-scores, we calculated two alternative sum score for AL to check if differences appear based on the method of operationalization. First, we assigned one point if the biomarker fell within high-risk categories based on clinical guidelines and summed them up to an overall sum score. Following previous studies, we decided to add half a point within a second alternative score for participants taking medication and who had low scores for blood pressure, glycohemoglobin, or lipids [10,67]. We found no difference in trends of AL comparing all three AL scores. Results of alternatively calculated AL scores can be found in the supplement (S3 Table). Taking this into consideration, we assume that the approach of using z-scores is appropriate in the context of our cohort.

Table 1. Biomarkers used to calculate AL score for comparison over time (Corresponding publications are indicated in brackets).

Biomarker Clinical cut-point
Waist circumference 94 cm for men and 80 cm for women [68]
Body Mass Index (BMI) 30 kg/m2 [68]
CRP a 3 mg/l [69]
Triglycerides 1,7 mmol/l (150 mg/dl) [70]
LDL b 3,0 mmol/l (115mg/dl) [70]
HDL c 1,0 mmol/l (40 mg/dl) for men
1,2 mmol/l (48mg/dl) for women [70]
HbA1 c d 7% (53 mmol/l) [70]
RR sys e 140 mmHg [70]
RR dia f 90 mmHg [70]

a c-reactive protein.

b low-density lipoprotein.

c high-density lipoprotein.

d glycated hemoglobin,

e systolic blood pressure,

f diastolic blood pressure

Other variables

In line with Lampert et al. (2013), we considered three variables as a surrogates to measure socioeconomic status [71]. The household net equivalent income (accounting for the number of persons in the household) at baseline was classified in seven categories (< 500€ = 1, 500 −< 750€ = 2, 750 −< 1000€ = 3, 1000 −< 1500€ = 4, 1500 −< 2000€ = 5, 2000 −< 2500€ = 6,>= 2500€ = 7) [57]. In order to differentiate between the impact of lower and higher net equivalent incomes on AL, we categorized net equivalent income in low and high income based on the median net equivalent income in east Germany in 2003 [72]. Participants having a net equivalent income lower than 1500 € were allocated to the low−income category.

Education was measured by the highest attained school education (no formal education = 1, elementary school (Hauptschule) = 2, secondary school (Realschule in FRG) = 3, secondary school (POS in GDR) = 4, qualified for university of applied sciences (Fachhochschulreife) = 5, A−levels/university entrance qualification (Abitur) = 6). Similarly with the procedure described above, we categorized into low educational level (secondary school or lower) and high educational level (secondary school (POS in GDR) or higher).

Professional status was measured in 7 categories (unskilled worker= 1, semiskilled, skilled worker, farmer = 2, foreman, assisting family, simple employee, lower civil servant = 3, employee foreman, qualified employee, middle civil servant = 4, self-employed <10 employees = 5, high qualified employee, higher civil servant, self-employed academic/professional =6, Employee with complex leadership, senior civil servant, self-employed>=10 employees = 7). We considered categories 1–4 as low professional level and 5–7 as high professional level.

To evaluate the influence of lifestyle variables, we took smoking status into account (current = 1, ex = 2, never = 3) and added cumulative pack years into the multiple regression model. Further, we included alcohol consumption (g/day) and physical activity (sport h/week) in our analysis. AL is also influenced by other social determinants of health like marital status and number of children. Therefore, we included marital status in our analysis coded as single=1, married=2, divorced=3 and widowed=4 and the number of biological children.

For medication use we took three measures into account: use of hypertension medication, use of lipid lowering medication and use of antidiabetic medication.

Statistical analysis

In a first step, we performed descriptive statistics to investigate AL in the study cohort at each of the three time points. Since our study is an exploratory analysis, we report means and confidence intervals instead of the p-value to avoid data dredging or p-hacking [73,74].

In a second step, we performed multiple linear regression to investigate the association of individual socioeconomic variables (income, education and professional status) and behavioral factors (use of tobacco, alcohol consumption, physical activity, marital status, number of children) with AL scores. As this study specifically aims to explore the association between these independent variables and AL scores within our cohort at different follow-ups, we rely on the baseline values of the predictors.

We adjusted for confounders such as age, sex, and medication use at the different time points. We emphasize that we have explicitly decided against adjusting for the baseline level of AL based on the following four reasons:

  1. Adjusting for the baseline value of a dependent variable carries the risk of collider bias. In this case, one controls for a variable that may be influenced both by the independent variables and by unobserved factors [75]. In the present model, this could lead to an overestimation of the associations between the independent variables and AL.

  2. As we are analyzing a cohort with a high average age, where some independent variables (e.g., educational attainment) exerted their effects long before the baseline examination, the AL at baseline partially reflects the associations with these independent variables [76]. Adjusting for AL at baseline would thus underestimate these associations.

  3. Adjusting for the AL at baseline would measure only the associations between the independent variables and AL that go beyond the effect of AL at baseline [77]. This would capture changes in AL, which is not the research focus of the present study.

  4. A correlation between the baseline value of a dependent variable and subsequent measurements is possible and could lead to overfitting, thereby impairing the predictive power and robustness of the model [78].

We applied two different models: For the first model, we explored associations between the different factors at baseline and AL scores after a mean follow-up of 4 years at the first follow-up (Model 1). For the second model, we aimed to investigate associations of these factors with AL scores at the third follow-up after a mean follow-up period of almost 17 years. Additionally, we applied each model separately for men and women. The statistical analyses were performed using the RStudio software environment.

Results

Demographic characteristics at baseline

The study sample consisted of 473 participants, of which 245 were men (52%) and 228 were women (48%) aged 45–80 years. The mean age at baseline examination was 58 years.

Considerable differences in baseline characteristics between men and women existed in their marital status, alcohol consumption, use of nicotine and cigarette pack-years: 83% of men but only 71% of women were married at baseline. In contrast, the percentage of widowed women was noticeably higher (10% of women vs. 2% of men), consistent with the typical age difference in marriages.

Sex differences were also evident in the lifestyle factors: On average, men consumed 3.6 times more alcohol than women (18.4 g/day vs. 5.2 g/day) and reported an average of 10.8 pack-years of tobacco, while women reported 3.9 pack-years. Also, only 36% of all men, but 66% of all women claimed to have never smoked. In addition, the proportion of current smokers was higher among men than among women (22% vs. 15%). Physical activity and the intake of medications were not found to be different between men and women. Details concerning the demographic, socioeconomic and behavioral variables at baseline are shown in Table 2.

Table 2. Demographic, socioeconomic and behavioral properties of the study population at baseline.

Characteristics Men
n=245
Women
n=238
All
n=473
mean age (years) 57.9 57.6 57.7
income lowa 50.2% 53.5% 51.8%
high 49.8% 46.5% 48.2%
education lowb 17.1% 19.7% 18.3%
high 82.9% 80.3% 81.6%
profession lowc 49.8% 77.2% 63.0%
high 52.2% 22.8% 37.0%
number of children (mean) 1.73 1.56 1.65
marital status divorced 11.0% 13.4% 12.2%
married 82.9% 71.1% 77.1%
single 4.1% 5.6% 4.8%
widowed 2.0% 9.9% 5.9%
use of nicotin current smoker 21.6% 14.5% 18.2%
ex smoker 42.9% 19.7% 31.7%
never smoked 35.5% 65.8% 50.1%
alcohol consumption g/day (mean) 18.4 5.2 12.0
pack-years of tabacco years (mean) 10.8 3.9 7.5
sport hours/week (mean) 0.95 0.94 0.95
antihypertensive medication yes 34.3% 42.1% 38.1%
lipid lowering medication yes 10.6% 7.9% 9.3%
antidiabetic medication yes 4.1% 4.8% 4.4%

aNet equivalent income of the household< 1500€.

bsecondary school or lower.

cunskilled worker, semiskilled, skilled worker, farmer, foreman, assisting family, simple employee or lower civil servant, employee foreman, qualified employee, middle civil servant

Changes of socioeconomic and behavioral characteristics over time

In our cohort, net equivalent income and professional status did not change noticeably from baseline to the first follow-up. Given that the youngest individual included in the cohort at baseline was 44 years old and the average age was 58 years, we can infer that there were no changes in school education during the follow-up period. As a result, we treated these variables as time-invariant and chose not to display them.

The proportion of participants taking antihypertensive drugs increased by 19 percentage points for women and 10 percentage points for men in the first follow-up compared to the baseline examination (S4 Table). Similar developments were seen for antidiabetic and lipid-lowering medication.

Further, lifestyle factors changed over time. At the time of the first follow−up, the proportion of current and occasional smokers decreased for both sexes compared to the proportion of current smokers at baseline examination (−5.2 percentage points for men and −3.4 percentage points for women). Further, hours of physical activity per week increased by 0.75 hours for men and 0.95 hours for women.

AL at baseline and in the follow-ups

Average AL scores decreased over time from −1.66 (95% CI: −1.98; −1.34) at baseline to −2.30 (95% CI: −2.57; −2.02) at the third follow−up. That means, in the 20 years between the examination, average AL decreased by about halve a standard deviation.

Men, participants with low education or professional level and participants who took antidiabetic or antihypertensive medication showed higher mean AL scores compared to the whole sub−cohort at all examinations. Further, information on mean AL scores for baseline and follow-up examinations stratified by sex and baseline characteristics are shown in Table 3.

Table 3. AL scores at baseline and follow-ups.

AL-score baseline
(n=473)
Mean
[95% CI]
AL-score first follow-up
(n=473)
Mean
[95% CI]
AL-score third follow-up
(n=473)
Mean
[95% CI]
total −1.66 −2.14 −2.30
[−1.98; −1.34] [−2.45; −1.83] [−2.57; −2.02]
sex* men (n = 245) −0.90 −1.63 −2.08
[−1.32; −0.48] [−2.04; −1.22] [−2.47; −1.70]
women (n = 228) −2.47 −2.69 −2.53
[−2.93; −2.01] [−3.16; −2.22] [−2.93; −2.12]
income * low income a −1.51 −2.02 −2,19
[−1.95; −1.07] [−2.46; −1,59] [−2.57; −1.81]
high income −1.81 −2.27 −2,41
[−2.28; −1.35] [−2.72; −1.82] [−2.81; −2.00]
education * low education b −0.96 −1.29 −2.01
[−1.69; −0.22] [−2.02; −0.56] [−2.62; −1.39]
high education −1.82 −2.33 −2.36
[−2.17; −1.46] [−2.67; −1.99] [−2.67; −2.05]
profession * low profession c −1.53 −1.85 −2.06
[−1.93; −1.12] [−2.25; −1.14] [−2.41; −1.71]
high profession −1.88 −2.64 −2.70
[−2.40; −1.37] [−3.12; −2.15] [−3.15; −2.26]
smoking status * current smoker −1.61 −2.37 −2.28
[−2.53; −0.69] [−3.28; −1.46] [−3.03; −1.55]
ex smoker −1.06 −1.75 −2.22
[−1.58; −0.54] [−2.27; −1.23] [−2.70; −1.74]
never smoked −2.05 −2.31 −2.35
[−2.48; −1.62] [−2.72; −1.90] [−2.73; −1.97]
marital status * single −2.08 −2.93 −2.72
[−3.55; −0.61] [−4.43; −1.43] [−3.99; −1.44]
married −1.49 −2.01 −2.17
[−1.86; −1.23] [−2.37; −1.66] [−2.49; −1.86]
divorced −2.34 −2.82 −2.78
[−3.14; −1.54] [−3.78; −1.87] [−3.62; −1.93]
widowed −2.06 −1.72 −2.61
[−3.49; −0.63] [−2.81; −0.62] [−3.73; −1.49]
use of medication * antihypertensive medication −0.49 −1.22 −1.89
[−0.98; 0.01] [−1.69; −0.74] [−2.35; −1.43]
lipidlowering medication −1.00 −1.07 −1.60
[−2.04; 0.03] [−2.20; −0.04] [−2.59; −0.61]
antidiabetic medication 0.75 0.97 −1.43
[−1.01; 2.51] [−0.90; 2.85] [−2.66; −0.20]

aNet equivalent income < 1500€

bsecondary school or lower

cunskilled worker, semiskilled, skilled worker, farmer, foreman, assisting family, simple employee or lower civ. Servant, employee foreman, qualified employee, middle civil servant

*

covariates assessed at baseline

Stratification by sex and age cohorts

At all examination times, women had a lower AL score than men. The decrease of AL scores for the whole sample was evident for men, but not for women. Thus, the AL score for men decreased from −0.90 (95% CI: −1.32; −0.48) at baseline to −2.08 (95% CI: −2.47; −1.70) at the third follow−up. In contrast, the mean AL score for women decreased from −2.47 (95% CI: −2.93; −2.01) at baseline to −2.69 (95%CI: −3.16; −2.22) at the first follow−up, but increased at the last follow−up to a level comparable to their baseline AL score (−2.53 (95% CI: −2.93; −2.12)).

The following boxplot (Fig 2) illustrates a stratified analysis of AL scores by sex and age. For parsimony and for illustrational purpose, we dichotomized our cohort in two categories (over vs. under 65 years). More detailed information about stratified analysis (including confidence intervals and all age cohorts) can be found in the supplement (S5 and S6 Tables). AL score of men in the younger age cohorts (<65 years) were higher than the AL score of women at all examination times and their AL score increased up to the age cohort of <65 years. During the examination period the AL score of each age cohort gradually decreased for men. Although women had lower scores than men in the age cohorts of <65 years, they overtook them at age cohorts over 65 years. Since confidence intervals for some age cohorts overlap, those results need to be interpreted cautiously.

Fig 2. AL scores stratified by sex and age cohorts at different examinations in the CARLA study.

Fig 2

Regression analyses

In the total analyzed sample, professional status was associated with AL scores in all models, whereby low status was connected to higher AL. When calculating separate regression models for each sex, this association persisted for men.

There was no association between education or income and AL scores in both models. In regards to lifestyle behaviors, hours of physical activity per week was negatively associated with AL scores at the both follow-ups in the total sample and for women. Further, we found an inverse association between age (in years) and AL scores at the first follow-up for women, but not for men. Interestingly, female sex was associated with lower AL scores at both follow-ups indicating sex differences of AL scores to decrease within an aging cohort. No associations were found for smoking status, consumption of alcohol and marital status. Results of regressions analyses are shown below (Table 4 and 5).

Table 4. Factors associated with AL score (multivariable regression analyses for the first follow up).

Model First Follow up (Total)
β
95%CI
Model First Follow up (men)
β
95%CI
Model First Follow up (women)
β
95%CI
(Intercept) −1.39 −3.33 −2.95
[−3.66, 0.88] [−6.73, 0.06] [−5.54, −0.36]
high income vs. lowa 0.44 0.56 0.15
[−0.20, 1.08] [−0.30, 1.43] [−0.84, 1.14]
high education vs. lowb −0.14 −0.37 0.06
[−1.02, 0.73] [−1.72, 0.98] [−1.20, 1.33]
high professionc vs. lowc −1.20 −1.06 −0.99
[−1.88, −0.52] [−2.02, −0.11] [−2.09, 0.11]
ex smokerd 0.27 0.03 0.18
[−0.72, 1.25] [−1.26, 1.32] [−1.64, 1.99]
never smokerd 0.27 −0.36 −0.12
[−0.90, 1.44] [−2.03, 1.31] [−2.30, 2.05]
marriede 0.28 1.59 −0.57
[−1.21, 1.77] [−1.24, 4.43] [−2.42, 1.28]
divorcede −0.09 1.25 −1.23
[−1.78, 1.60] [−1.91, 4.41] [−3.25, 0.79]
widowede 0.60 1.66 −0.56
[−1.07, 2.27] [−1.23, 4.55] [−2.53, 1.42]
packyearsf 0.04 0.16 −0.48
[−0.46, 0.54] [−0.50, 0.82] [−1.22, 0.25]
consumption of alcoholf 0.11 0.01 0.09
[−0.27, 0.48] [−0.43, 0.46] [−0.41, 0.60]
sportf −0.54 −0.31 −0.74
[−0.82, −0.26] [−0.72, 0.09] [−1.17, −0.32]
number of childrenf 0.26 0.16 0.33
[−0.08, 0.61] [−0.38, 0.69] [−0.10, 0.77]
agef 0.19 −0.29 0.80
[−0.07, 0.59] [−0.77, 0.19] [0.31, 1.28]
women vs. men −1.21
[−1.93, −0.49]
antidiabetic mediaction vs. no 1.54 1.45 1.75
[0.92, 2.16] [0.56, 2.33] [0.85, 2.66]
lipidlowering medication vs. no −0.34 −0.41 −0.05
[−1.15, 0.47] [−1.56, 0.75] [−1.27, 1.17]
antihypertensive medication vs. no 2.55 2.75 2.11
[0.71, 4.38] [0.12, 5.38] [−0.49, 7.70]
N 473 245 228
R2 0.21 0.17 0.31

Standard errors are heteroskedasticity robust.

aNet equivalent income per person < 1500€,

bsecondary school or lower,

cunskilled worker, semiskilled, skilled worker, farmer, foreman, assisting family, simple employee or lower civil servant, employee foreman, qualified employee, middle civil servant

dreference: current smoker,

ereference: single,

fContinuous predictors are scaled by 1 s.d.

Table 5. Factors associated with AL score (multivariable regression analyses for the third follow-up).

Model Second follow-up (total) β [95%CI] Model Second follow-up (men) β [95%CI] Model Second follow-up (women) β [95%CI]
(Intercept) − 2.11 −1.15 −4.79
[−4.04, −0.17] [−3.95, 1.64] [−7.67, −1.91]
high income vs. lowa 0.15 −0.59 0.73
[−0.43, 0.72] [−1.42, 0.25] [−0.11, 1.57]
high education vs. lowb −0.20 0.42 −0.67
[−0.95, 0.55] [−0.84, 1.68] [−1.72, 0.39]
high professionc vs. lowc −0.83 −0.72 −0.58
[−1.44, −0.23] [−1.61, 0.17] [−1.52, 0.35]
ex smokerd −0.06 −0.84 0.82
[−0.93, 0.81] [−1.91, 0.24] [−0.99, 2.63]
never smokerd 0.16 −1.04 1.08
[−0.86, 1.17] [−2.32, 0.25] [−1.05, 3.21]
marriede 0.44 −0.47 0.97
[−0.90, 1.79] [−2.79, 1.86] [−0.97, 2.92]
divorcede 0.05 −0.84 0.29
[−1.45, 1.55] [−3.39, 1.71] [−1.83, 2.42]
widowede 0.12 −1.89 0.81
[−1.62, 1.86] [−6.12, 2.34] [−1.45, 3.06]
packyearsf 0.06 −0.04 0.03
[−0.34, 0.46] [−0.53, 0.46] [−0.71, 0.78]
consumption of alcoholf 0.11 0.06 −0.04
[−0.18, 0.40] [−0.30 0.43] [−0.55, 0.46]
sportf −0.40 −0.08 −0.63
[−0.66, −0.15] [−0.46, 0.30] [−0.99, −0.26]
number of childrenf 0.15 0.19 0.15
[−0.13, 0.44] [−0.23, 0.61] [−0.26, 0.55]
agef −0.14 −0.37 0.16
[−0.44, 0.17] [−0.85, 0.11] [−0.30, 0.62]
women vs. men −0.69
[−1.30, −0.08]
antidiabetic medication vs. no 1.79 2.12 1.42
[0.90, 2.68] [0.92, 3.31] [0.07, 2.77]
lipidlowering medication vs. no −1.76 −1.81 −1.57
[−2.35, −1.17] [−2.63, −0.99] [−2.46, −0.68]
antihypertensive medication vs. no 1.61 1.41 1.61
[1.02, 2.20] [0.59, 3.31] [0.66, 2.55]
N 473 245 228
R² 0.18 0.24 0.24

Standard errors are heteroskedasticity robust.

aNet equivalent income per person < 1500€,

bsecondary school or lower,

cunskilled worker, semiskilled, skilled worker, farmer, foreman, assisting family, simple employee or lower civil servant, employee foreman, qualified employee, middle civil servant

dreference: current smoker,

ereference: divorced,

fContinuous predictors are scaled by 1 s.d.

Discussion

We found a decrease of average AL scores in our analyzed sample over the follow-up period. This trend was evident for men, but only partially for women. Our stratified statistical analysis for men and women revealed differences in the association of the professional status and AL scores. In regards to behavioral variables, only physical activity was associated with AL scores, while smoking and alcohol consumption did not exhibit relations with AL scores.

In reference to the decreased AL scores over time, it is important to note that some systematic changes occurred during the follow-up period. In particular, participants with systolic blood pressure measurements exceeding >140/90 mmHg at baseline were instructed to inform their physician. In the follow-up, we observed a substantially higher proportion of participants with hypertensive medication. Thus, the observed improvement in controlled blood pressure could have resulted from this intervention, leading to advantageous AL scores, particularly for men [79]. Similarly, increased attention towards health problems resulting from the baseline examination could have led to the increase of physical activity levels and reduced percentage of current smokers that we have seen at the first follow-up. The potential effects of these shifting lifestyles cannot be conclusively evaluated due to low retention and the risk of selection bias. Most previous research has shown increasing trends of AL scores for aging cohorts [14,45,56]. This observation of increasing AL scores with time is also biologically plausible, since the chronic maladaptation to stress – which is measured by AL – accumulates over time [6]. Meanwhile, in our sample the accumulation of stressors over time seems to have been countered by changes in lifestyle.

We found women to have a lower AL score at all examinations, but distinct patterns of AL scores over the time were evident when comparing sexes. In a stratified analysis for sex and age cohorts, mean AL scores of men in the younger age cohorts (<65 years) were higher than the AL score of women at all examination times, but lower in the older age cohorts, suggesting different pathways for men and women. These observations are in line with a study by Yang and Kozloski, who found women to have a lower AL score than men, but with a steep postmenopausal increase that persisted after adjusting for other covariates, causing women to have higher AL scores than men approximately 10 years after menopause [43].

Despite the fact that women overtook men in AL score at older ages in our cohort compared to investigations by Yang and Kozloski, we found similar developments, which we suspect in sex-specific hormonal differences. Yang and Kozloski described a lag of 5–10 years between the mean age of menopause and the increase of female AL scores. They explained this lag due to the wide use of estrogen replacement therapies among U.S. women and the latency of physiological dysregulation [43]. We observed a lag of almost 15 years after mean age of menopause in our cohort (49 years) that might be explained by the inaccuracy that arises through the stratification in age groups of 5 years. Overall, these sex-specific results are consistent with previous research [43,45,46].

Moreover, we found that a low professional level was associated with low AL scores at the last follow-up in the whole sample. In the analysis performed separately for the sexes, this relation did was more visible for men. In contrast with our findings, Dowd et al. found adolescent socioeconomic status independently inversely related to AL only for women after adjustment for smoking, snuff use, alcohol and physical inactivity [48]. Another study found lower occupational status strongly negatively correlated with AL, supporting our results [80].

The potential difference in the relevance of the professional status for AL between men and women does not align with the literature beyond socioeconomic status: Further environmental stressors have also been found to be stronger predictors of AL for women than for men [81]. Interestingly, Gustafsson et al. found low socioeconomic status at 43 years related to higher AL. After adjustment for tobacco, alcohol use and physical activity, these effects were attenuated in men but not women [9]. Overall, literature indicates that the effect of low socioeconomic status among men is mediated by known behavioral risk factors, while for women the association between socioeconomic status and health is weaker and the pathway unclear.

Regarding behavioral variables, we found hours of physical activity per week negatively correlated with AL scores at both follow-up’s for women and the total sample. These findings are partially consistent with results of Gay et al., who found a significant relation between high levels of activity and lower total allostatic load compared to sedentary participants after adjustment for age, sex and education [32]. Although they found a negative association between levels of activity and AL, they did not find significant influences on AL scores across moderate and low active groups. In reference to the relatively low duration of physical activity in our cohort, the effect on AL score even after a long follow-up period remains and raises the question about the dose-response-relationship between physical activity and AL. Even though our results are congruent with previous studies [17,32,33,46,82], there is a need for further investigations to study the dose-response-relationship between physical activity and AL.

In our analysis, alcohol consumption was not associated with AL scores. Other studies found a positive relation between alcohol consumption and AL [16,33,41]. Petrovic et al. found heavy drinking men, and women abstaining from alcohol to have a higher AL than moderate drinkers [17]. In line with findings of Hawkley et al., who showed that the use of current abstainers as the reference group leads to systematic bias, our results may be interpreted as a result of misclassification [15] since abstainers, who may already suffer the consequences of previous alcohol consumption are measured the same as non-drinkers. This relationship has been described as J-shaped and may have occurred in our study [83]. Similar connections to those described and a sample size that is comparatively limited could have resulted in smoking status having no impact on AL scores.

Strength and limitations of the study

The main strength of the study is that it is based on the extensive set of clinical, laboratory, and lifestyle information over a long follow-up period in a population-based study sample. This allowed us to compare the AL scores of the study cohort across three cross-sections, stratified by sex and age cohorts.

Further, the data provided the chance to investigate determinants of AL in a longitudinal cohort study, with a mean follow-up period of 17 years and conduct sex-specific analyses.

Nonetheless, our results should be interpreted in light of their limitations. The persons included in our analyses are those who were still alive and willing to participate up to 20 years after baseline examination. Although interviews were performed by trained study nurses, sociodemographic and behavioral data relies on self-reported answers, which may have led to a recall bias. We suspected the chosen method of operationalizing of AL to partially explain the contrary results of the development of AL over the follow-up period as we were not able to incorporate medication use in our AL score. Nonetheless, Geronimus et al. 2006 stated that this approach is sensible within cohorts of older ages in which prevalence of chronic diseases are high [53]. In this regard, we highlight the high prevalence of hypertension, type 2 diabetes and a high average BMI (28 kg/m2) at baseline [58]. Since there is no consensus about the operationalization of AL, our procedure of adding up calculated z-scores has some advantages over other approaches, especially considering the multiple measurements of AL scores. To address these requirements, we chose to calculate z-scores for each biomarker and added up each biomarker’s z-score to an overall AL score. This approach might also be more precise to estimate associations of different factors with AL scores and allows to compare AL scores within the same cohort over the observation period. However, alternative methods to calculate AL scores led to similar results.

Conclusion

We examined changes in AL scores over time and explored the potential determinants influencing these scores. The results demonstrated a decrease in AL scores from baseline examination to the third follow-up for men and a plateau for women. This may be partially explained by an improvement in healthcare and changed lifestyle behaviors. Interestingly, the changes in AL scores were distinct for men and women. Notably, women exhibited lower mean AL scores than men in the younger age cohorts, but this trend reversed 15 years after the mean age of menopausal transition, with women surpassing men in the same age cohorts. These results imply that men and women experience distinct aging patterns, as indicated by the varying levels of physiological burden measured by AL.

Furthermore, socioeconomic variables were found to impact AL scores differently for men and women. Specifically, low professional status was associated with higher AL scores for men but not for women. These findings suggest that time-invariant socioeconomic factors, such as professional status, may exert a long-lasting influence on health, but the importance of specific socioeconomic factors varies between sexes.

The study also examined the relationship between lifestyle factors and AL scores. Hours of physical activity per week exhibited a negative correlation with AL scores, indicating that higher levels of physical activity may contribute to lower AL scores especially showing an impact on women. However, the precise amount of physical activity required to achieve this effect needs further investigation. In contrast, alcohol consumption showed a no correlation with AL scores, potentially influenced by misclassification and an abstainer bias.

In summary, this study provides valuable insights into the dynamics of AL scores over time, highlighting the role of sex, socioeconomic variables, and lifestyle factors in shaping individual health outcomes. These findings contribute to our understanding of the complex interplay between various factors and AL, paving the way for future research aimed at developing targeted interventions and public health strategies to improve health and well-being.

Supporting information

S1 Table. Descriptive summary for the whole sample.

(DOCX)

pone.0321178.s001.docx (16.5KB, docx)
S2 Table. Counts of missing data points for biomarkers at baseline and follow-up examinations.

(DOCX)

pone.0321178.s002.docx (15.2KB, docx)
S3 Table. Comparison of different calculation methods for AL scores Mean [95% CI].

(DOCX)

pone.0321178.s003.docx (14.5KB, docx)
S4 Table. characteristics of time-variant variables at first follow-up (sub-cohort).

(DOCX)

pone.0321178.s004.docx (16.2KB, docx)
S5 Table. AL scores stratified by age cohorts for men.

(DOCX)

pone.0321178.s005.docx (15.3KB, docx)
S6 Table. AL scores stratified by age cohorts for women.

(DOCX)

pone.0321178.s006.docx (15.3KB, docx)

Acknowledgments

We are grateful to all of the participants in the CARLA-cohort, to the survey staff and research nurses who made this study possible. Further, we want to thank Alexander Kluttig and Lena Minning for the additional work in data preparation.

Abbreviations

AL

Allostatic Load

BMI

Body Mass Index

CARLA

Cardiovascular risk factors, living and ageing in Halle

CI

Confidence Interval

CRP

C-reactive Protein

HbA1c

Glycated Hemoglobin

HDL

High-density Lipoprotein Cholesterol

LDL

Low-density Lipoprotein Cholesterol

RR

Blood pressure

SES

Socioeconomic Status

Data Availability

Restrictions apply to the availability of these data due to legal restrictions. The data was used under license for the current study, and is therefore not publicly available. The data that support the findings of this study are available from the steering committee upon reasonable request and with permission of the CARLA Study steering committee. Researchers interested in the data can apply for the data by sending an email to [carlastudie@uk-halle.de] or through submitting an application form that is available on the CARLA study website https://webszh.uk-halle.de/carla-studie/. To access the data, a formal application must be submitted with a detailed research proposal consisting of a title, authors, research questions, brief scientific background, list of needed variables, and proposed statistical analyses. All proposals will be reviewed by the CARLA Study steering committee and a final decision on the use of data will be given.

Funding Statement

We acknowledge the financial support of the Open Access Publication Fund of the Martin-Luther-University Halle-Wittenberg. The funders did not influence the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Schneiderman N, Ironson G, Siegel SD. Stress and health: psychological, behavioral, and biological determinants. Annu Rev Clin Psychol. 2005;1:607–28. doi: 10.1146/annurev.clinpsy.1.102803.144141 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Yaribeygi H, Panahi Y, Sahraei H, Johnston TP, Sahebkar A. The impact of stress on body function: a review. EXCLI J. 2017;16:1057–72. doi: 10.17179/excli2017-480 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Noushad S, Ahmed S, Ansari B, Mustafa U-H, Saleem Y, Hazrat H. Physiological biomarkers of chronic stress: a systematic review. Int J Health Sci (Qassim). 2021;15(5):46–59. [PMC free article] [PubMed] [Google Scholar]
  • 4.Juster RP, McEwen BS, Lupien SJ. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev. 2010;35(1):2–16. doi: 10.1016/j.neubiorev.2009.10.002 [DOI] [PubMed] [Google Scholar]
  • 5.McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338(3):171–9. doi: 10.1056/NEJM199801153380307 [DOI] [PubMed] [Google Scholar]
  • 6.McEwen BS. Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci. 1998;840:33–44. doi: 10.1111/j.1749-6632.1998.tb09546.x [DOI] [PubMed] [Google Scholar]
  • 7.Mauss D, Li J, Schmidt B, Angerer P, Jarczok MN. Measuring allostatic load in the workforce: A systematic review. Ind Health. 2015;53(1):5–20. doi: 10.2486/indhealth.2014-0122 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Duong MT, Bingham BA, Aldana PC, Chung ST, Sumner AE. Variation in the calculation of allostatic load score: 21 examples from NHANES. J Racial Ethn Health Disparities. 2017;4(3):455–61. doi: 10.1007/s40615-016-0246-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gustafsson PE, Janlert U, Theorell T, Westerlund H, Hammarström A. Socioeconomic status over the life course and allostatic load in adulthood: results from the Northern Swedish Cohort. J Epidemiol Community Health. 2011;65(11):986–92. doi: 10.1136/jech.2010.108332 [DOI] [PubMed] [Google Scholar]
  • 10.Rodriquez EJ, Kim EN, Sumner AE, Nápoles AM, Pérez-Stable EJ. Allostatic load: importance, markers, and score determination in minority and disparity populations. J Urban Health. 2019;96(Suppl 1):3–11. doi: 10.1007/s11524-019-00345-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Beckie TM. A systematic review of allostatic load, health, and health disparities. Biol Res Nurs. 2012;14(4):311–46. doi: 10.1177/1099800412455688 [DOI] [PubMed] [Google Scholar]
  • 12.Robertson T, Beveridge G, Bromley C. Allostatic load as a predictor of all-cause and cause-specific mortality in the general population: evidence from the Scottish health survey. PLoS One. 2017;12(8):e0183297. doi: 10.1371/journal.pone.0183297 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Parker HW, Abreu AM, Sullivan MC, Vadiveloo MK. Allostatic load and mortality: a systematic review and meta-analysis. Am J Prev Med. 2022;63(1):131–40. [DOI] [PubMed] [Google Scholar]
  • 14.Karlamangla AS, Singer BH, McEwen BS, Rowe JW, Seeman TE. Allostatic load as a predictor of functional decline. MacArthur studies of successful aging. J Clin Epidemiol. 2002;55(7):696–710. doi: 10.1016/s0895-4356(02)00399-2 [DOI] [PubMed] [Google Scholar]
  • 15.Seeman TE, McEwen BS, Rowe JW, Singer BH. Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc Natl Acad Sci U S A. 2001;98(8):4770–5. doi: 10.1073/pnas.081072698 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Guidi J, Lucente M, Sonino N, Fava GA. Allostatic load and its impact on health: A systematic review. Psychother Psychosom. 2021;90(1):11–27. [DOI] [PubMed] [Google Scholar]
  • 17.Petrovic D, Pivin E, Ponte B, Dhayat N, Pruijm M, Ehret G, et al. Sociodemographic, behavioral and genetic determinants of allostatic load in a Swiss population-based study. Psychoneuroendocrinology. 2016;67:76–85. doi: 10.1016/j.psyneuen.2016.02.003 [DOI] [PubMed] [Google Scholar]
  • 18.Upchurch DM, Stein J, Greendale GA, Chyu L, Tseng CH, Huang MH, et al. A longitudinal investigation of race, socioeconomic status, and psychosocial mediators of allostatic load in midlife women: Findings from the study of women’s health across the nation. Psychosom Med. 2015;77(4):402–12. doi: 10.1097/PSY.0000000000000175 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Milad E, Bogg T. Personality traits, coping, health-related behaviors, and cumulative physiological health in a national sample: 10 year prospective effects of conscientiousness via perceptions of activity on allostatic load. Ann Behav Med. 2020;54(11):880–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Johnson SC, Cavallaro FL, Leon DA. A systematic review of allostatic load in relation to socioeconomic position: Poor fidelity and major inconsistencies in biomarkers employed. Soc Sci Med. 2017;192:66–73. doi: 10.1016/j.socscimed.2017.09.025 [DOI] [PubMed] [Google Scholar]
  • 21.Singer B, Ryff CD. Hierarchies of life histories and associated health risks. Ann N Y Acad Sci. 1999;896:96–115. doi: 10.1111/j.1749-6632.1999.tb08108.x [DOI] [PubMed] [Google Scholar]
  • 22.Kubzansky LD, Kawachi I, Sparrow D. Socioeconomic status, hostility, and risk factor clustering in the Normative Aging Study: Any help from the concept of allostatic load?. Ann Behav Med. 1999;21(4):330–8. [DOI] [PubMed] [Google Scholar]
  • 23.Hawkley LC, Lavelle LA, Berntson GG, Cacioppo JT. Mediators of the relationship between socioeconomic status and allostatic load in the Chicago health, aging, and social relations study (CHASRS). Psychophysiology. 2011;48(8):1134–45. doi: 10.1111/j.1469-8986.2011.01185.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Lipowicz A, Szklarska A, Malina RM. Allostatic load and socioeconomic status in Polish adult men. J Biosoc Sci. 2014;46(2):155–67. doi: 10.1017/S0021932013000345 [DOI] [PubMed] [Google Scholar]
  • 25.Robertson T, Watts E. The importance of age, sex and place in understanding socioeconomic inequalities in allostatic load: Evidence from the Scottish Health Survey (2008-2011). BMC Public Health. 2016;16:126. doi: 10.1186/s12889-016-2905-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Weinstein M, Goldman N, Hedley A, Yu-Hsuan L, Seeman T. Social linkages to biological markers of health among the elderly. J Biosoc Sci. 2003;35(3):433–53. [DOI] [PubMed] [Google Scholar]
  • 27.Robertson T, Popham F, Benzeval M. Socioeconomic position across the lifecourse & allostatic load: data from the West of Scotland Twenty-07 cohort study. BMC Public Health. 2014;14:184. doi: 10.1186/1471-2458-14-184 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Xu H. Multilevel socioeconomic differentials in allostatic load among Chinese adults. Health Place. 2018;53:182–92. doi: 10.1016/j.healthplace.2018.08.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Präg P, Richards L. Intergenerational social mobility and allostatic load in Great Britain. J Epidemiol Community Health. 2019;73(2):100–5. doi: 10.1136/jech-2017-210171 [DOI] [PubMed] [Google Scholar]
  • 30.Schnorpfeil P, Noll A, Schulze R, Ehlert U, Frey K, Fischer JE. Allostatic load and work conditions. Soc Sci Med. 2003;57(4):647–56. doi: 10.1016/s0277-9536(02)00407-0 [DOI] [PubMed] [Google Scholar]
  • 31.Bellingrath S, Weigl T, Kudielka BM. Chronic work stress and exhaustion is associated with higher allostastic load in female school teachers. Stress. 2009;12(1):37–48. doi: 10.1080/10253890802042041 [DOI] [PubMed] [Google Scholar]
  • 32.Gay JL, Salinas JJ, Buchner DM, Mirza S, Kohl HW HW, Fisher-Hoch SP, et al. Meeting physical activity guidelines is associated with lower allostatic load and inflammation in Mexican Americans. J Immigr Minor Health. 2015;17(2):574–81. doi: 10.1007/s10903-013-9950-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Forrester SN, Leoutsakos JM, Gallo JJ, Thorpe RJ, Seeman TE. Association between allostatic load and health behaviours: A latent class approach. J Epidemiol Community Health. 2019;73(4):340–5. doi: 10.1136/jech-2018-211289 [DOI] [PubMed] [Google Scholar]
  • 34.Bei B, Seeman TE, Carroll JE, Wiley JF. Sleep and physiological dysregulation: A closer look at sleep intraindividual variability. Sleep. 2017;40(9). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Clark AJ, Dich N, Lange T, Jennum P, Hansen AM, Lund R, et al. Impaired sleep and allostatic load: Cross-sectional results from the Danish copenhagen aging and midlife biobank. Sleep Med. 2014;15(12):1571–8. doi: 10.1016/j.sleep.2014.07.013 [DOI] [PubMed] [Google Scholar]
  • 36.Mattei J, Noel SE, Tucker KL. A meat, processed meat, and French fries dietary pattern is associated with high allostatic load in Puerto Rican older adults. J Am Diet Assoc. 2011;111(10):1498–506. doi: 10.1016/j.jada.2011.07.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Mattei J, Bhupathiraju S, Tucker KL. Higher adherence to a diet score based on American Heart Association recommendations is associated with lower odds of allostatic load and metabolic syndrome in Puerto Rican adults. J Nutr. 2013;143(11):1753–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Lee KH, Park SW, Ye SM, Kim S-Y, Kim S-Y, Han JS, et al. Relationships between dietary habits and allostatic load index in metabolic syndrome patients. Korean J Fam Med. 2013;34(5):334–46. doi: 10.4082/kjfm.2013.34.5.334 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.van Draanen J, Prelip M, Upchurch DM. Consumption of fast food, sugar-sweetened beverages, artificially-sweetened beverages and allostatic load among young adults. Prev Med Rep. 2017;10:212–7. doi: 10.1016/j.pmedr.2017.11.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Ottino-González J, Jurado MA, García-García I, Caldú X, Prats-Soteras X, Tor E, et al. Allostatic load and executive functions in overweight adults. Psychoneuroendocrinology. 2019;106:165–70. doi: 10.1016/j.psyneuen.2019.04.009 [DOI] [PubMed] [Google Scholar]
  • 41.Gallo LC, Jiménez JA, Shivpuri S, Espinosa de los Monteros K, Mills PJ. Domains of chronic stress, lifestyle factors, and allostatic load in middle-aged Mexican-American women. Ann Behav Med. 2011;41(1):21–31. doi: 10.1007/s12160-010-9233-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Sotos-Prieto M, Bhupathiraju SN, Falcón LM, Gao X, Tucker KL, Mattei J. A healthy lifestyle score is associated with cardiometabolic and neuroendocrine risk factors among Puerto Rican adults. J Nutr. 2015;145(7):1531–40. doi: 10.3945/jn.114.206391 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Yang Y, Kozloski M. Sex differences in age trajectories of physiological dysregulation: Inflammation, metabolic syndrome, and allostatic load. J Gerontol A Biol Sci Med Sci. 2011;66(5):493–500. doi: 10.1093/gerona/glr003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Gallagher S, Kate MB. Caregiving and allostatic load predict future illness and disability: a population-based study. Brain Behav Immun Health. 2021;16:100295. doi: 10.1016/j.bbih.2021.100295 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.van Deurzen I, Vanhoutte B. A longitudinal study of allostatic load in later life: the role of sex, birth cohorts, and risk accumulation. Res Aging. 2019;41(5):419–42. doi: 10.1177/0164027518813839 [DOI] [PubMed] [Google Scholar]
  • 46.Tampubolon G, Maharani A. Trajectories of allostatic load among older Americans and Britons: Longitudinal cohort studies. BMC Geriatr. 2018;18(1):255. doi: 10.1186/s12877-018-0947-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Seeman TE, Singer BH, Ryff CD, Dienberg Love G, Levy-Storms L. Social relationships, gender, and allostatic load across two age cohorts. Psychosom Med. 2002;64(3):395–406. [DOI] [PubMed] [Google Scholar]
  • 48.Dowd JB, Goldman N. Do biomarkers of stress mediate the relation between socioeconomic status and health?. J Epidemiol Community Health. 2006;60(7):633–9. doi: 10.1136/jech.2005.040816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Seeman TE, Robbins RJ. Aging and hypothalamic-pituitary-adrenal response to challenge in humans. Endocr Rev. 1994;15(2):233–60. [DOI] [PubMed] [Google Scholar]
  • 50.Gruenewald TL, Seeman TE, Karlamangla AS, Sarkisian CA. Allostatic load and frailty in older adults. J Am Geriatr Soc. 2009;57(9):1525–31. doi: 10.1111/j.1532-5415.2009.02389.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Fried LP, Xue QL, Cappola AR, Ferrucci L, Chaves P, Varadhan R, et al. Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. J Gerontol A Biol Sci Med Sci. 2009;64(10):1049–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Ding YY, Kuha J, Murphy M. Multidimensional predictors of physical frailty in older people: identifying how and for whom they exert their effects. Biogerontology. 2017;18(2):237–52. doi: 10.1007/s10522-017-9677-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Crimmins EM, Johnston M, Hayward M, Seeman T. Age differences in allostatic load: an index of physiological dysregulation. Exp Gerontol. 2003;38(7):731–4. doi: 10.1016/s0531-5565(03)00099-8 [DOI] [PubMed] [Google Scholar]
  • 54.Crook Z, Booth T, Cox SR, Corley J, Dykiert D, Redmond P, et al. Apolipoprotein E genotype does not moderate the associations of depressive symptoms, neuroticism and allostatic load with cognitive ability and cognitive aging in the Lothian Birth Cohort 1936. PLoS One. 2018;13(2):e0192604. doi: 10.1371/journal.pone.0192604 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Seeman TE. Price of adaptation—Allostatic load and its health consequences. Arch Intern Med. 1997;157(19):2259. doi: 10.1001/archinte.1997.00440400111013 [DOI] [PubMed] [Google Scholar]
  • 56.Merkin SS, Karlamangla A, Roux AV, Shrager S, Seeman TE. Life course socioeconomic status and longitudinal accumulation of allostatic load in adulthood: multi-ethnic study of atherosclerosis. Am J Public Health. 2014;104(4):e48-55. doi: 10.2105/AJPH.2013.301841 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Greiser KH, Kluttig A, Schumann B, Kors JA, Swenne CA, Kuss O, et al. Cardiovascular disease, risk factors and heart rate variability in the elderly general population: design and objectives of the CARdiovascular disease, living and ageing in Halle (CARLA) Study. BMC Cardiovasc Disord. 2005;5:33. doi: 10.1186/1471-2261-5-33 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Haerting J, Kluttig A, Greiser KH, Nuding S, Werdan K. A cohort study investigating risk factors for cardiovascular disease in an urban elderly East-German population (CARLA study). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2012;55(6–7):795–800. doi: 10.1007/s00103-012-1493-4 [DOI] [PubMed] [Google Scholar]
  • 59.Hassan L, Efremov L, Großkopf A, Kartschmit N, Medenwald D, Schott A, et al. Cardiovascular risk factors, living and ageing in Halle: the CARLA study. Eur J Epidemiol. 2022;37(1):103–16. doi: 10.1007/s10654-021-00824-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Ittermann T, Dörr M, Markus MRP, Nauck M, Jürgens C, Schipf S, et al. Variability of biomarkers used for the classification of metabolic syndrome: a repeated measurements study. Nutr Metab Cardiovasc Dis. 2022;32(7):1693–702. doi: 10.1016/j.numecd.2022.03.022 [DOI] [PubMed] [Google Scholar]
  • 61.Sidhu D, Naugler C. Fasting time and lipid levels in a community-based population: a cross-sectional study. Arch Intern Med. 2012;172(22):1707–10. doi: 10.1001/archinternmed.2012.3708 [DOI] [PubMed] [Google Scholar]
  • 62.Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation. 2008;118(20):2047–56. doi: 10.1161/CIRCULATIONAHA.108.804146 [DOI] [PubMed] [Google Scholar]
  • 63.Nordestgaard BG, Langsted A, Mora S, Kolovou G, Baum H, Bruckert E, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J. 2016;37(25):1944–58. doi: 10.1093/eurheartj/ehw152 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Zhang Z. Multiple imputation with multivariate imputation by chained equation (MICE) package. Ann Transl Med. 2016;4(2):30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.McLoughlin S, Kenny RA, McCrory C. Does the choice of allostatic load scoring algorithm matter for predicting age-related health outcomes?. Psychoneuroendocrinology. 2020;120:104789. doi: 10.1016/j.psyneuen.2020.104789 [DOI] [PubMed] [Google Scholar]
  • 66.Levine ME, Crimmins EM. A comparison of methods for assessing mortality risk. Am J Hum Biol. 2014;26(6):768–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Geronimus AT, Hicken M, Keene D, Bound J. “Weathering” and age patterns of allostatic load scores among blacks and whites in the United States. Am J Public Health. 2006;96(5):826–33. doi: 10.2105/AJPH.2004.060749 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Urban, Vogel. S3-Leitlinie zur prävention und therapie der adipositas“aktualisiert. CardioVasc. 2014;14(3):18. doi: 10.1007/s15027-014-0392-z [DOI] [Google Scholar]
  • 69.Ridker PM. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation. 2003;108(12):e81-5. [DOI] [PubMed] [Google Scholar]
  • 70.Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–88. doi: 10.1093/eurheartj/ehz455 [DOI] [PubMed] [Google Scholar]
  • 71.Lampert T. Messung des sozioökonomischen Status in der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz. 2013;56:631–6. [DOI] [PubMed] [Google Scholar]
  • 72.Bundesamt S. Wirtschaftsrechnungen: einkommens- und Verbrauchsstichprobe, Einkommensverteilung in Deutschland. Wiesbaden; 2006.
  • 73.Goodman S. A dirty dozen: twelve p-value misconceptions. Semin Hematol. 2008;45(3):135–40. doi: 10.1053/j.seminhematol.2008.04.003 [DOI] [PubMed] [Google Scholar]
  • 74.Elston DM. Cherry picking, HARKing, and P-hacking. J Am Acad Dermatol. 2021. [DOI] [PubMed] [Google Scholar]
  • 75.Hernán MA, Monge S. Selection bias due to conditioning on a collider. BMJ. 2023;381:1135. doi: 10.1136/bmj.p1135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Glymour MM, Weuve J, Berkman LF, Kawachi I, Robins JM. When is baseline adjustment useful in analyses of change? An example with education and cognitive change. Am J Epidemiol. 2005;162(3):267–78. doi: 10.1093/aje/kwi187 [DOI] [PubMed] [Google Scholar]
  • 77.(CHMP) CfMPfHU. Guideline on adjustment for baseline covariates in clinical trials. Eur Med Agency Sci Med Health. London; 2015. [Google Scholar]
  • 78.Babyak MA. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med. 2004;66(3):411–21. doi: 10.1097/01.psy.0000127692.23278.a9 [DOI] [PubMed] [Google Scholar]
  • 79.Lacruz ME, Kluttig A, Hartwig S, Löer M, Tiller D, Greiser KH, et al. Prevalence and incidence of hypertension in the general adult population: results of the CARLA-cohort study. Medicine (Baltimore). 2015;94(22):e952. doi: 10.1097/MD.0000000000000952 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Juster R-P, Moskowitz DS, Lavoie J, D’Antono B. Sex-specific interaction effects of age, occupational status, and workplace stress on psychiatric symptoms and allostatic load among healthy Montreal workers. Stress. 2013;16(6):616–29. doi: 10.3109/10253890.2013.835395 [DOI] [PubMed] [Google Scholar]
  • 81.Mair CA, Cutchin MP, Kristen Peek M. Allostatic load in an environmental riskscape: The role of stressors and gender. Health Place. 2011;17(4):978–87. doi: 10.1016/j.healthplace.2011.03.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Upchurch DM, Rainisch BW, Chyu L. Greater leisure time physical activity is associated with lower allostatic load in white, black, and Mexican American midlife women: findings from the National Health and Nutrition Examination Survey, 1999 through 2004. Womens Health Issues. 2015;25(6):680–7. doi: 10.1016/j.whi.2015.07.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Roerecke M, Rehm J. Alcohol consumption, drinking patterns, and ischemic heart disease: A narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med. 2014;12:182. doi: 10.1186/s12916-014-0182-6 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Andrey I Egorov

30 Dec 2024

PONE-D-24-31153Allostatic Load and its determinants in a German sample – Results from the Carla cohort.PLOS ONE

Dear Dr. Priedemann,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 13 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Andrey I Egorov

Academic Editor

PLOS ONE

Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.  When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. Thank you for stating the following financial disclosure: "We acknowledge the financial support of the Open Access Publication Fund of the Martin-Luther 498 University Halle-Wittenberg." Please state what role the funders took in the study.  If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. 5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 6. We notice that your supplementary tables are included in the manuscript file. Please remove them and upload them with the file type 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The article "Allostatic Load and its Determinants in a German Sample - Results from the Carla Cohort" aims to describe changes in allostatic load over time and to identify longitudinal determinants of allostatic load. The allostatic load index includes information on metabolic, immune, cardiovascular and anthropometric measures. The results show longitudinal changes in allostatic load among men. Allostatic load was associated with occupational status and physical activity. The article includes many analyses, but should be revised to focus more on the research objective.

Lines 42-44: The conclusion does not follow the results - what public health interventions are meant?

The background section gives a good overview of the existing literature, but needs to be rewritten to focus on the research aim.

Is the first aim the description of changes over time or the trend of AL over time in different age groups?

Lines 160-169: Please include a flow chart

Table 1: Add "Biomarkers used to calculate AL score for comparison over time" to clarify that cut points are only used in this version of the score.

Statistical Analysis: Please add information about the statistical analysis software used

Lines 261-265: Add more information about the type of statistical model used. Is the baseline level of the AL score included as an independent variable? Explain why you used different models rather than one model that included change in score and determinants over time? Especially since lifestyle factors and medication use changed over the observation period (lines 283-297).

Table 3: Are the categories shown baseline covariates?

Lines 363-364: this was not a result of this study and very speculative. Could be a selection bias due to loss to follow-up.

Strenghts and Limitations: Are the AL scores based on single measures at 1 time point? Then add information on intra-individual variability of serum lipids and blood pressure and thus misclassification bias.

Reviewer #2: Authors assessed the allostatic load from the German Carla cohort.

This study was properly conducted and evaluated.

However, biomarkers used in the study was too basic, hence if plasma samples are available, authors should perform latest biomarkers such as following cortisol, VILIP-1 and MBP.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  Julia Truthmann

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2025 Apr 24;20(4):e0321178. doi: 10.1371/journal.pone.0321178.r003

Author response to Decision Letter 1


5 Feb 2025

We sincerely thank you for your thorough review and valuable feedback on our manuscript. Your insightful comments and suggestions have significantly helped us to refine and improve the quality of our work. We deeply appreciate the time and effort you invested in reviewing our paper, and we are grateful for your constructive input. Below, we address each of your comments in detail.

Sincerely,

Eric Priedemann for the authors

Reviewer #1

Comment 1: Lines 42-44: The conclusion does not follow the results - what public health interventions are meant? - Our current findings do not allow for specific public health interventions but indicate subgroup-specific influences of chronic stress on aging processes. As you correctly pointed out, the previously used phrasing was overly broad and has been revised accordingly.

Comment 2: The background section gives a good overview of the existing literature, but needs to be rewritten to focus on the research aim. - Your comment helped us improve the transition from the current state of research on allostatic load to our specific research question. This transition has been supplemented with paragraphs highlighting the research gaps in the existing literature and leading into our research questions. We hope this serves as a helpful link that makes it easier for readers to understand the outlined issue.

Comment 3: Is the first aim the description of changes over time or the trend of AL over time in different age groups? – To clarify our objective, the first research question has been split into two questions:

1. Do mean AL scores change in the CARLA-cohort over the study period for CARLA?

We aim to investigate how the AL scores change within the cohort over the study period.

2. Do mean AL scores change differently for men and women and within age-groups?

We also aim to examine whether the observed changes in AL scores at the study time point differ between sex and age cohorts (measured at baseline). Specifically, we are investigating whether participants under 55 years of age at baseline show different changes in AL scores compared to participants aged 65-70 years at baseline.

Comment 4: Lines 160-169: Please include a flow chart - A flow chart has been added (Fig. 1).

Comment 5: Table 1: Add "Biomarkers used to calculate AL score for comparison over time" to clarify that cut points are only used in this version of the score. – We included this specification in the heading of Table 1.

Comment 6: Statistical Analysis: Please add information about the statistical analysis software used – We used the RStudio software environment for statistical analyses. This information was added at the end of the method section.

Comment 7: Lines 261-265: Add more information about the type of statistical model used. Is the baseline level of the AL score included as an independent variable? Explain why you used different models rather than one model that included change in score and determinants over time? Especially since lifestyle factors and medication use changed over the observation period (lines 283-297). –

As this paper specifically aims to explore the association between the independent variables and AL scores within our cohort at different follow-ups, we rely on the baseline values of the predictors.

We have explicitly decided against adjusting for the baseline level of AL based on the following four reasons:

1. Adjusting for the baseline value of a dependent variable carries the risk of collider bias. In this case, one controls for a variable that may be influenced both by the independent variables and by unobserved factors (1). In the present model, this could lead to an overestimation of the associations between the independent variables and AL.

2. As we are analyzing a cohort with a high average age, where some independent variables (e.g., educational attainment) exerted their effects long before the baseline examination, the AL at baseline partially reflects the associations with these independent variables (2). Adjusting for AL at baseline would thus underestimate these associations.

3. Adjusting for the AL at baseline would measure only the associations between the independent variables and AL that go beyond the effect of AL at baseline (3). This would capture changes in AL, which is not the research focus of the present study.

4. A correlation between the baseline value of a dependent variable and subsequent measurements is possible and could lead to overfitting, thereby impairing the predictive power and robustness of the model (4).

Furthermore, your comment points to another very interesting question regarding the trajectories of AL and potential factors influencing the baseline level as well as the increase or decrease of AL. Due to the significant scope of these different questions, we had to refrain from addressing them within the scope of this paper. A second paper, which addresses this intriguing question, is currently under review (5).

Comment 8: Table 3: Are the categories shown baseline covariates? - In Table 3, we used baseline values of the covariates. As such, it represents a stratification of AL scores based on the covariates measured at baseline. We have added this information in the table legend for clarification.

Comment 9: Lines 363-364: this was not a result of this study and very speculative. Could be a selection bias due to loss to follow-up. – In the revised version, we acknowledge the lifestyle changes that occurred during the study period, which could have potentially led to an improvement in the AL scores. However, we emphasize that, due to the low retention rate, no conclusions can be made regarding any association.

Comment 10: Strenghts and Limitations: Are the AL scores based on single measures at 1 time point? Then add information on intra-individual variability of serum lipids and blood pressure and thus misclassification bias. - The venous blood samples were taken from non-fasting participants once at each examination. In the revised version, we point out the resulting intraindividual variations; however, due to the completion of the studies, we are unable to make any methodological changes. In addition to this natural fluctuation, which can lead to misclassification of participants (as you rightly pointed out), significant intraindividual variation is also a risk factor for cardiovascular endpoints, meaning a "falsely high" value also represents a part of the cardiovascular risk and chronic stress of the body. Moreover, the use of lipid-lowering medications has different effects on these fluctuations, as it is known, for example, that the use of long-acting statins or PCSK-9 inhibitors results in less fluctuation of serum-lipids than shorter-acting statins (6). Since this precise specification is not evident from the study data, and the value of these different influences on AL cannot be reliably quantified, we believe that pointing out the existing fluctuations is sufficient. We are very grateful for this suggestion and appreciate this detailed scientific discourse, which contributes to a better understanding of AL.

Reviewer #2

Comment 11: Authors assessed the allostatic load from the German Carla cohort.

This study was properly conducted and evaluated.

However, biomarkers used in the study was too basic, hence if plasma samples are available, authors should perform latest biomarkers such as following cortisol, VILIP-1 and MBP. – Thank you for your helpful suggestion regarding our work. In selecting biomarkers for AL, we focused on including markers from different systems. However, we were constrained by the availability of data and the need for consistent and comprehensive collection of these biomarkers across all the follow-ups used. The score we employed reflects the maximum overlap given these limitations and cannot be expanded further due to the unavailability of additional biomarkers.

Literature used for the response to the reviewers

1. Hernan MA, Monge S. Selection bias due to conditioning on a collider. BMJ. 2023;381:1135.

2. Glymour MM, Weuve J, Berkman LF, Kawachi I, Robins JM. When is baseline adjustment useful in analyses of change? An example with education and cognitive change. Am J Epidemiol. 2005;162(3):267-78.

3. (CHMP) CfMPfHU. Guideline on adjustment for baseline covariates in clinical

trials. European Medicines Agency Science Medicines Health; London2015.

4. Babyak MA. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med. 2004;66(3):411-21.

5. Priedemann EN, Kluttig A, Kraus FB, Sedding D, Mikolajczyk R, Führer A. Association between Social Mobility, Social Status and trajectories of Allostatic Load – A longitudinal analysis of the Carla cohort. Stress and Health. in submission.

6. Simpson WG. Biomarker variability and cardiovascular disease residual risk. Curr Opin Cardiol. 2019;34(4):413-7.

Attachment

Submitted filename: Response to Reviewers.doc

pone.0321178.s008.doc (54.5KB, doc)

Decision Letter 1

Andrey I Egorov

4 Mar 2025

Allostatic Load and its determinants in a German sample – Results from the Carla cohort.

PONE-D-24-31153R1

Dear Dr. Priedemann,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Andrey I Egorov

Academic Editor

PLOS ONE

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  Julia Truthmann

**********

Acceptance letter

Andrey I Egorov

PONE-D-24-31153R1

PLOS ONE

Dear Dr. Priedemann,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Andrey I Egorov

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Descriptive summary for the whole sample.

    (DOCX)

    pone.0321178.s001.docx (16.5KB, docx)
    S2 Table. Counts of missing data points for biomarkers at baseline and follow-up examinations.

    (DOCX)

    pone.0321178.s002.docx (15.2KB, docx)
    S3 Table. Comparison of different calculation methods for AL scores Mean [95% CI].

    (DOCX)

    pone.0321178.s003.docx (14.5KB, docx)
    S4 Table. characteristics of time-variant variables at first follow-up (sub-cohort).

    (DOCX)

    pone.0321178.s004.docx (16.2KB, docx)
    S5 Table. AL scores stratified by age cohorts for men.

    (DOCX)

    pone.0321178.s005.docx (15.3KB, docx)
    S6 Table. AL scores stratified by age cohorts for women.

    (DOCX)

    pone.0321178.s006.docx (15.3KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.doc

    pone.0321178.s008.doc (54.5KB, doc)

    Data Availability Statement

    Restrictions apply to the availability of these data due to legal restrictions. The data was used under license for the current study, and is therefore not publicly available. The data that support the findings of this study are available from the steering committee upon reasonable request and with permission of the CARLA Study steering committee. Researchers interested in the data can apply for the data by sending an email to [carlastudie@uk-halle.de] or through submitting an application form that is available on the CARLA study website https://webszh.uk-halle.de/carla-studie/. To access the data, a formal application must be submitted with a detailed research proposal consisting of a title, authors, research questions, brief scientific background, list of needed variables, and proposed statistical analyses. All proposals will be reviewed by the CARLA Study steering committee and a final decision on the use of data will be given.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES